United States · FDA National Drug Code directory
Cisatracurium Besylate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70069-161_16bbec4b-027e-470e-aac9-e041bc5e24f5
- Product NDC
- 70069-161
- Form
- INJECTION
- Composition / generic term
- Cisatracurium Besylate
- Labeler
- Somerset Therapeutics, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190802
- Source listing expiry
- 20271231
Source-listed ingredients
- CISATRACURIUM BESYLATE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (70069-161-01) / 10 mL in 1 VIAL · 70069-161-01
- 10 VIAL, MULTI-DOSE in 1 CARTON (70069-161-10) / 10 mL in 1 VIAL, MULTI-DOSE · 70069-161-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →